Comparative Study
doi: 10.1128/AAC.15.4.518.
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
- PMID: 380462
- PMCID: PMC352703
- DOI: 10.1128/AAC.15.4.518
Item in Clipboard
Comparative Study
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
Antimicrob Agents Chemother.
1979 Apr.
Abstract
Thienamycin, a new beta-lactam antibiotic, exhibited potent, broad-spectrum activity in vitro against gram-negative bacilli and gram-positive cocci, including many isolates resistant to currently available antibiotics. All isolates were inhibited at concentrations less than or equal to 25 mug/ml, with the exception of 12% of isolates of Enterobacter spp. and 3% of isolates of Serratia marcescens. Its activity decreased with an increase in inoculum concentration of from 10(5) to 10(7) cells per ml.
Similar articles
-
Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.J Antibiot (Tokyo). 1979 Oct;32(10):1019-24. doi: 10.7164/antibiotics.32.1019. J Antibiot (Tokyo). 1979. PMID: 528361
-
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273. Antimicrob Agents Chemother. 1980. PMID: 6247970 Free PMC article.
-
Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.Chemotherapy. 1996 Sep-Oct;42(5):334-42. doi: 10.1159/000239464. Chemotherapy. 1996. PMID: 8874972
-
Antibacterial activity of imipenem: the first thienamycin antibiotic.Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S389-410. doi: 10.1093/clinids/7.supplement_3.s389. Rev Infect Dis. 1985. PMID: 3931196 Review.
-
Review of the in vitro spectrum of activity of imipenem.Am J Med. 1985 Jun 7;78(6A):22-32. doi: 10.1016/0002-9343(85)90098-1. Am J Med. 1985. PMID: 3890537 Review.
Cited by
-
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.Antimicrob Agents Chemother. 1982 Jan;21(1):180-7. doi: 10.1128/AAC.21.1.180. Antimicrob Agents Chemother. 1982. PMID: 6979306 Free PMC article.
-
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.Chem Rev. 2021 Jul 14;121(13):7957-8094. doi: 10.1021/acs.chemrev.1c00138. Epub 2021 Jun 15. Chem Rev. 2021. PMID: 34129337 Free PMC article. Review.
-
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.Antimicrob Agents Chemother. 1982 Jan;21(1):168-9. doi: 10.1128/AAC.21.1.168. Antimicrob Agents Chemother. 1982. PMID: 6952818 Free PMC article.
-
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.Antimicrob Agents Chemother. 1980 Oct;18(4):557-61. doi: 10.1128/AAC.18.4.557. Antimicrob Agents Chemother. 1980. PMID: 6934707 Free PMC article.
-
In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.Antimicrob Agents Chemother. 1981 Jan;19(1):114-6. doi: 10.1128/AAC.19.1.114. Antimicrob Agents Chemother. 1981. PMID: 6787975 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
